Amgen Gets US Infliximab Nod

Amgen’s Avsola Rival To Remicade Is Its Fourth FDA-Approved Biosimilar

 
• By David Wallace
  
Amgen
Amgen has received an FDA approval for its Avsola version of infliximab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products